The 3rd World Congress on Thyroid Cancer will take place in the gorgeous city of Boston USA in July 2017. The Organizing Committee has already commenced program planning and all details will be available on this website as the planning progresses.
This international meeting builds on the success of WCTC1 in 2009 with 770 delegates and WCTC2 in 2013 with 1010 delegates.
WCTC3 is expected to attract more than 1,200 delegates to participate in cutting edge scientific program that will feature:
Panels / Debates
Meet the Professor
Taking advantage of the unique offerings of Boston, there will be a limited number of attractive options for those wishing to extend their stay and bring their families with pre and post tours of Cape Cod and Newport. Leisure time activities for delegates and guests will be offered to take full advantage of Boston. More details will be available soon!
Make plans now to join us in Boston July 27 – 30, 2017!
The objective of this Congress is to:
Foster a collegial multidisciplinary atmosphere amongst all stakeholders for the discussion of management of and research in thyroid cancer
Discuss and demonstrate all state of the art aspects for the management of and research in the field of thyroid oncology worldwide
Create the groundwork for future direction for management of and research in thyroid cancer
State of the art information, presentations and discussion:
Advances and innovations
REGISTRATION NOW OPEN!
Gregory W. Randolph, MD, Co-Chair Bryan McIver, MD, Co-Chair Ezra Cohen, MD Jeremy Freeman, MD Bryan Haugen, MD Jatin P. Shah, MD Ashok R. Shaha, MD Steven I. Sherman, MD Ian J. Witterick, MD